Assessing trends in chlamydia positivity and gonorrhea incidence and their associations with the incidence of pelvic inflammatory disease and ectopic pregnancy in Washington State, 1988-2010

Sexually Transmitted Diseases

Volumn 43, Issue 1, 2016, Pages 2-8

  Moore, Miranda S ^a   Golden, Matthew R ^a,b   Scholes, Delia ^a,c   Kerani, Roxanne P ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b PUBLIC HEALTH SEATTLE AND KING COUNTY   (United States)

^c CENTER FOR HEALTH STUDIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CHLAMYDIASIS; DISEASE ASSOCIATION; ECTOPIC PREGNANCY; FEMALE; GONORRHEA; HUMAN; INCIDENCE; INFECTION RATE; MAJOR CLINICAL STUDY; NUCLEIC ACID AMPLIFICATION; OUTCOME ASSESSMENT; OUTPATIENT; PELVIC INFLAMMATORY DISEASE; PREVALENCE; SCREENING; TREND STUDY; UNITED STATES; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; COMPLICATION; ISOLATION AND PURIFICATION; PREGNANCY; PREGNANCY, ECTOPIC; WASHINGTON; YOUNG ADULT;

ADOLESCENT; ADULT; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; FEMALE; GONORRHEA; HUMANS; INCIDENCE; PELVIC INFLAMMATORY DISEASE; PREGNANCY; PREGNANCY, ECTOPIC; WASHINGTON; YOUNG ADULT;

EID: 84951908221     PISSN: 01485717     EISSN: 15374521     Source Type: Journal    
DOI: 10.1097/OLQ.0000000000000352     Document Type: Article

References (34)

1. Centers for Disease Control and Prevention. Summary of notifiable diseases-United States, 2011. MMWR 2013; 60: 1-117.
2. Brunham RC, Binns B, Guijon F, Etiology and outcome of acute pelvic inflammatory disease. J Infect Dis 1988; 158: 510-517.
3. Shaw JL, Dey SK, Critchley HO, Current knowledge of the aetiology of human tubal ectopic pregnancy. Hum Reprod Update 2010; 16: 432-444.
4. Simms I, Stephenson JM,. Pelvic inflammatory disease epidemiology: What do we know and what do we need to know? Sex Transm Infect 2000; 76: 80-87.
5. van Valkengoed IG, Morré SA, van den Brule AJ, Overestimation of complication rates in evaluations of Chlamydia trachomatis screening programmes-Implications for cost-effectiveness analyses. Int J Epidemiol 2004; 33: 416-425.
6. Taylor BD, Haggerty CL,. Management of Chlamydia trachomatis genital tract infection: Screening and treatment challenges. Infect Drug Resist 2011; 4: 19-29.
7. Risser WL, Risser JM, Benjamins LJ,. Pelvic inflammatory disease in adolescents between the time of testing and treatment and after treatment for gonorrhoeal and chlamydial infection. Int J STD AIDS 2012; 23: 457-458.
8. Britton TF, Delisle S, Fine D,. STDs and family planning clinics: A regional program for chlamydia control that works. Am J Gynecol Health 1992; 6: 80-87.
9. Oakeshott P, Kerry S, Atherton H, Community-based trial of screening for Chlamydia trachomatis to prevent pelvic inflammatory disease: The POPI (Prevention of Pelvic Infection) trial. Trials 2008; 9: 73.
10. Scholes D, Stergachis A, Heidrich FE, Prevention of pelvic inflammatory disease by screening for cervical chlamydial infection. N Engl J Med 1996; 334: 1362-1366.
11. Ostergaard L, Andersen B, Møller JK, Home sampling versus conventional swab sampling for screening of Chlamydia trachomatis in women: A cluster-randomized 1-year follow-up study. Clin Infect Dis 2000; 31: 951-957.
12. Low N, Egger M, Sterne JA, Incidence of severe reproductive tract complications associated with diagnosed genital chlamydial infection: The Uppsala Women's Cohort Study. Sex Transm Infect 2006; 82: 212-218.
13. Clark KL, Howell MR, Li Y, Hospitalization rates in female US Army recruits associated with a screening program for Chlamydia trachomatis. Sex Transm Dis 2002; 29: 1-5.
14. Low N, Bender N, Nartey L, Effectiveness of chlamydia screening: Systematic review. Int J Epidemiol 2009; 38: 435-448.
15. Egger M, Low N, Smith GD, Screening for chlamydial infections and the risk of ectopic pregnancy in a county in Sweden: Ecological analysis. BMJ 1998; 316: 1776-1780.
16. Scholes D, Satterwhite CL, Yu O, Long-Term trends in Chlamydia trachomatis infections and related outcomes in a U.S. managed care population. Sex Transm Dis 2012; 39: 81-88.
17. Anschuetz GL, Asbel L, Spain CV, Association between enhanced screening for Chlamydia trachomatis and Neisseria gonorrhoeae and reductions in sequelae among women. J Adolesc Health 2012; 51: 80-85.
18. Moss NJ, Ahrens K, Kent CK, The decline in clinical sequelae of genital Chlamydia trachomatis infection supports current control strategies. J Infect Dis 2006; 193: 1336-1338; author reply 1338-9.
19. Rekart ML, Gilbert M, Meza R, Chlamydia public health programs and the epidemiology of pelvic inflammatory disease and ectopic pregnancy. J Infect Dis 2013; 207: 30-38.
20. Trabert B, Holt VL, Yu O, Population-based ectopic pregnancy trends, 1993-2007. Am J Prev Med 2011; 40: 556-160. Erratum in: Am J Prev Med. 2012; 42(1):107.
21. Sutton MY, Sternberg M, Zaidi A, Trends in pelvic inflammatory disease hospital discharges and ambulatory visits, United States, 1985-2001. Sex Transm Dis 2005; 32: 778-784.
22. Miller WC, Siripong N,. Estimates of sexually transmitted infection prevalence and incidence in the United States: Time to embrace uncertainty. Sex Transm Dis 2013; 40: 194-196.
23. Miller WC,. Epidemiology of chlamydial infection: Are we losing ground? Sex Transm Infect 2008; 84: 82-86.
24. Fine D, Dicker L, Mosure D, Increasing chlamydia positivity in women screened in family planning clinics: Do we know why? Sex Transm Dis 2008; 35: 47-52.
25. Dicker LW, Mosure DJ, Levine WC, Impact of switching laboratory tests on reported trends in Chlamydia trachomatis infections. Am J Epidemiol 2000; 151: 430-435.
26. Dicker LW, Mosure DJ, Levine WC,. Chlamydia positivity versus prevalence. What's the difference? Sex Transm Dis 1998; 25: 251-253.
27. Centers for Disease Control and Prevention. Sexually Transmitted Disease Surveillance 2010. Atlanta, GA: Department of Health and Human Services; 2011.
28. IMS Institute for Healthcare Informatics. HSRN data brief: National Disease and Therapeutic Index™. Available at: http://www.imshealth.com/deployedfiles/ims/Global/Content/Insights/Researchers/NDTI-Brief.pdf. Accessed April 18, 2014.
29. Centers for Disease Control and Prevention. Sexually Transmitted Disease Surveillance 2000. Atlanta, GA: Department of Health and Human Services; 2001.
30. McDonald SA, Presanis AM, De Angelis D, An evidence synthesis approach to estimating the incidence of seasonal influenza in the Netherlands. Influenza Other Respir Viruses 2014; 8: 33-41.
31. Sweeting MJ, De Angelis D, Hickman M, Estimating hepatitis C prevalence in England and Wales by synthesizing evidence from multiple data sources. Assessing data conflict and model fit. Biostatistics 2008; 9: 715-734.
32. Herzog SA, Althaus CL, Heijne JC, Timing of progression from Chlamydia trachomatis infection to pelvic inflammatory disease: A mathematical modelling study. BMC Infect Dis 2012; 12: 187.
33. Aral SO, Fenton KA, Holmes KK,. Sexually transmitted diseases in the USA: Temporal trends. Sex Transm Infect 2007; 83: 257-266.
34. Golden MR, Kerani RP, Stenger M, Uptake and population-level impact of expedited partner therapy (EPT) on Chlamydia trachomatis and Neisseria gonorrhoeae: The Washington State community-level randomized trial of EPT. PLoS Med 2015: 12.